Å©½Ç·Î¿À½º ½ÃÀå ±Ô¸ð : À¯Çüº°, Çüź°, ÃÖÁ¾ ¿ëµµº°, ¼ºÀå Àü¸Á, Áö¿ªº° Àü¸Á°ú ¼¼°è ¿¹Ãø(2024-2032³â)
Xylose Market Size - By Type (D-Xylose, L-Xylose), By Form (Powder, Liquid), By End Use (Food & Beverage, Pharmaceuticals, Animal Feed, Cosmetics & Personal Care), Growth Prospects, Regional Outlook & Global Forecast, 2024 - 2032
»óǰÄÚµå
:
1434008
¸®¼Ä¡»ç
:
Global Market Insights Inc.
¹ßÇàÀÏ
:
2024³â 01¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 180 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
Å©½Ç·Î¿À½º ½ÃÀå ±Ô¸ð´Â 2024-2032³â CAGR 6.5%·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
ÀÌ·¯ÇÑ Çö»óÀº ½Äǰ ¹× À½·á ºÐ¾ß¿¡¼ ÀúÄ®·Î¸® °¨¹Ì·á¿Í õ¿¬ °¨¹Ì·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. »ýȰ½À°üº´ Áõ°¡·Î ÀÎÇØ °Ç°°ú À£ºù¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
Å©½Ç·Î¿À½º´Â ±× ±â´ÉÀû Ư¼ºÀ¸·Î ÀÎÇØ Á¦¾à ¹× ÈÀåǰ »ê¾÷¿¡¼ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Å©½Ç·Î¿À½º »ý»ê ¹æ¹ýÀÇ ±â¼ú ¹ßÀü°ú Çõ½ÅÀûÀÎ ÀÀ¿ëÀ» À§ÇÑ ¿¬±¸°³¹ß Ȱµ¿ÀÇ ±ÞÁõÀº Á¦Ç° ¼ö¿ä¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 7¿ù, Healtang Biotech Co., Ltd.´Â ½Äǰ ¼ººÐ¿¡ »ç¿ëÇϱâ À§ÇÑ D-Å©½Ç·Î¿À½º ¹× L-¾Æ¶óºñ³ë½º »ý»ê¿¡ ´ëÇØ ISO22000, MUI HALAL, FSSC22000 µî ¿©·¯ ÀÎÁõÀ» ȹµæÇß½À´Ï´Ù. ¶ÇÇÑ Å©½Ç·Î¿À½ºÀÇ Ä£È¯°æÀû Ư¼º¿¡ °É¸Â´Â Áö¼Ó°¡´ÉÇÑ ¹ÙÀÌ¿À Á¦Ç°¿¡ ´ëÇÑ Àü ¼¼°èÀûÀÎ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ »ê¾÷ ¹ßÀü¿¡ À¯¸®ÇÑ È¯°æÀ» Á¶¼ºÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
Å©½Ç·Î¿À½º »ê¾÷Àº À¯Çü, ÇüÅÂ, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªÀ¸·Î ºÐ·ùµË´Ï´Ù.
À¯Çüº°·Î´Â L-Å©½Ç·Î¿À½º ºÎ¹® ½ÃÀå °¡Ä¡´Â 2024-2032³â ¿¬Æò±Õ 6.8%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ´Â Á¦¾à ¹× °Ç° º¸Á¶ ½Äǰ »ê¾÷¿¡¼ ´Ù¾çÇÑ À̼ºÁúü¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. °Ç° ÁöÇâÀû Á¦Ç°¿¡¼ L-Å©½Ç·Î¿À½ºÀÇ Á߿伺ÀÌ Áõ°¡ÇÏ°í ¶Ñ·ÇÇÑ Æ¯¼ºÀÌ ÀÌ ºÎ¹®ÀÇ È®ÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
Á¦¾à »ê¾÷ÀÇ ÃÖÁ¾ ¿ëµµ ºÐ¾ß¿¡¼ Å©½Ç·Î¿À½º ½ÃÀå Á¡À¯À²Àº 2032³â±îÁö 6.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â Á¦¾à Á¦Á¦¿¡¼ Å©½Ç·Î¿À½ºÀÇ »ç¿ëÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. Å©½Ç·Î¿À½º´Â ÀǾàǰÀÇ ¾ÈÁ¤¼º°ú ¿ëÇØµµ¸¦ Çâ»ó½ÃŰ´Â °Í ¿Ü¿¡µµ ´Ù¾çÇÑ ÀǾàǰ ¿ëµµ¿¡ ÀûÇÕÇϱ⠶§¹®¿¡ äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¿´ÉÀ» Çâ»ó½ÃŰ´Â »õ·Î¿î ÀǾàǰ Á¦Á¦ °³¹ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ÀÌ ºÐ¾ßÀÇ ¼ºÀå¿¡ ÈûÀ» ½Ç¾îÁÖ°í ÀÖ½À´Ï´Ù.
Áö¿ªº°·Î º¸¸é À¯·´ÀÇ Å©½Ç·Î¿À½º »ê¾÷ ±Ô¸ð´Â 2024-2032³â 6.9%ÀÇ ¼ºÀå·ü·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±× ¹è°æ¿¡´Â Áö¼Ó°¡´ÉÇÑ ¹ÙÀÌ¿À Á¦Ç°¿¡ ´ëÇÑ °ÇÑ °ü½É°ú À½·á ¹× ½Äǰ »ê¾÷¿¡¼ õ¿¬ °¨¹Ì·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ Á¦¾à ¹× ÈÀåǰ ºÐ¾ß¿¡¼ÀÇ Àû¿ë ¹üÀ§ È®´ë¿Í °Ç° ÁöÇâÀûÀÎ ¼ÒºñÀÚ ¼±Åÿ¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö´Â °Íµµ ÀÌ Áö¿ª ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÏ°Ô ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Å©½Ç·Î¿À½º »ê¾÷ ÀλçÀÌÆ®
- ¿¡ÄڽýºÅÛ ºÐ¼®
- ¿ø·á ºÐ¼®
- Á¦Á¶¾÷ü
- ÃÖÁ¾ ¿ëµµ ºÐ¼®
- ÀÌÀÍ·ü ºÐ¼®
- º¥´õ ¸ÅÆ®¸¯½º
- ¿øÀç·á ºÐ¼®
- ±â¼ú Àü¸Á
- ±ÔÁ¦ »óȲ
- ºÏ¹Ì
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- °¡°Ý ºÐ¼®
- ºÏ¹Ì
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ºñ¿ë ±¸Á¶ ºÐ¼®, 2023³â
- ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
- ÃËÁø¿äÀÎ
- ½Äǰ ¹× À½·á¿¡¼ õ¿¬¡¤½Ä¹° À¯·¡ ¿ø·á¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡
- ÀǾàǰ ¿ëµµ¿¡¼ Å©½Ç·Î¿À½ºÀÇ »ç¿ë È®´ë
- Å©½Ç·Î¿À½º ½ÃÀå¿¡¼ÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú Á¦Ç° °³¹ß
- ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
- ±âŸ õ¿¬ °¨¹Ì·á ¹× ¼³ÅÁ ´ëüǰ°úÀÇ Ä¡¿ÇÑ °æÀï
- ±â¼ú Çõ½Å°ú Áö¼Ó°¡´É¼º
- ¼ºÀå °¡´É¼º ºÐ¼®, 2023³â
- PorterÀÇ »ê¾÷ ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå °æÀï ±¸µµ
- ¼·Ð
- ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
- ¼¼°è ±â¾÷ Á¡À¯À² ºÐ¼®
- °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
- Àü·« ´ë½Ãº¸µå
Á¦5Àå Å©½Ç·Î¿À½º ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Çüº°
- ÁÖ¿ä À¯Çü µ¿Çâ
- D-Å©½Ç·Î¿À½º
- L-Å©½Ç·Î¿À½º
Á¦6Àå Å©½Ç·Î¿À½º ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Çüź°
Á¦7Àå Å©½Ç·Î¿À½º ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÃÖÁ¾ ¿ëµµº°
- ÁÖ¿ä ÃÖÁ¾ ¿ëµµ µ¿Çâ
- ½Äǰ ¹× À½·á »ê¾÷
- ÀǾàǰ »ê¾÷
- µ¿¹° »ç·á »ê¾÷
- ÈÀåǰ¡¤ÆÛ½º³ÎÄÉ¾î »ê¾÷
- ±âŸ
Á¦8Àå Å©½Ç·Î¿À½º ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°
- ÁÖ¿ä µ¿Çâ : Áö¿ªº°
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ÀÌÅ»¸®¾Æ
- ³×´ú¶õµå
- Æú¶õµå
- ·¯½Ã¾Æ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- È£ÁÖ
- Çѱ¹
- Àεµ³×½Ã¾Æ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
Á¦9Àå ±â¾÷ °³¿ä
- Ardilla Technologies Limited
- AvanceChem
- Central Drug House P
- Healtang Biotech Co.
- International Flavour & Fragrance Limited
- Penta Manufacturer
- Sinofi Ingredients
- Spectrum Chemicals
- Sure Chemicals Co. Ltd.
- Shandong Xieli Bio-tech Co., Ltd.
- Stora Enso
- Futaste Co., Ltd.
- Shandong LuJian Biological Technology Co., Ltd.
- Anyang City Yuxin Xylitol Technology Co., Ltd.
- Jilin Yuxin Biotechnology Co., Ltd.
KSA
¿µ¹® ¸ñÂ÷
Xylose market size is projected to expand at 6.5% CAGR from 2024 to 2032, due to the rising demand for low-calorie sweeteners and natural alternatives in the food & beverage sector. The growing prevalence of lifestyle-related diseases is leading to the increasing awareness of health and wellness.
Xylose is increasingly used in the pharmaceutical and cosmetics industries owing to its functional properties. The rising technological advancements in xylose production methods and the surge in R&D activities for innovative applications will add to the product demand. For instance, in July 2022, Healtang Biotech Co., Ltd. secured several certifications, including ISO22000, MUI HALAL, FSSC22000, and others for the production of D-Xylose and L-arabinose, intended for use in food ingredients. Additionally, the global emphasis on sustainable and bio-based products to match the eco-friendly nature of xylose will create a favorable environment for the industry development.
The xylose industry is segregated into type, form, end-use, and region.
Based on type, the market value from the L-Xylose segment is estimated to rise at 6.8% CAGR from 2024 to 2032, owing to the rising demand for several isomers to cater to applications in the pharmaceutical and nutraceutical industries. The growing significance of L-Xylose in health-focused products and its distinct properties will further drive the segment expansion.
Xylose market share from the pharmaceutical industry end-use segment is projected to witness 6.8% CAGR through 2032. This is due to the increasing utilization of xylose in pharmaceutical formulations. In addition to enhancing drug stability and solubility, xylose offers compatibility with various pharmaceutical applications, adding to its increased adoption. Moreover, the growing emphasis on developing novel pharmaceutical formulations with improved efficacy will boost the segment growth.
Regionally, the Europe xylose industry size is projected to expand at 6.9% growth rate between 2024 and 2032. This can be attributed to the strong focus on sustainable and bio-based products and the rising demand for natural sweeteners in the food & beverage industry. Furthermore, the increasing application scope in pharmaceuticals and cosmetics sectors along with the growing awareness of health-conscious consumer choices will also favor the regional market growth.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Base estimates & workings
- 1.3 Forecast parameters
- 1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Data mining source
- 1.4.2.1 Paid sources
- 1.4.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Xylose industry 360 degree synopsis, 2018 - 2032
- 2.2 Business trends
- 2.3 Type trends
- 2.4 Form trends
- 2.5 End use trends
- 2.6 Regional trends
Chapter 3 Xylose Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Raw material analysis
- 3.1.2 Manufacturers
- 3.1.3 End use analysis
- 3.1.4 Profit margin analysis
- 3.1.5 Vendor matrix
- 3.2 Raw material analysis
- 3.3 Technology landscape
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 APAC
- 3.4.4 Latin America
- 3.4.5 MEA
- 3.5 Pricing analysis
- 3.5.1 North America
- 3.5.2 Europe
- 3.5.3 Asia Pacific
- 3.5.4 Latin America
- 3.5.5 Middle East & Africa
- 3.5.6 Cost structure analysis, 2023
- 3.6 Industry impact forces
- 3.6.1 Growth drivers
- 3.6.1.1 Increased demand for natural and plant-based ingredients in food and beverages.
- 3.6.1.2 Expanding usage of Xylose in pharmaceutical applications.
- 3.6.1.3 Continued innovation and product development in the Xylose market.
- 3.6.2 Industry pitfalls & challenges
- 3.6.2.1 Intense competition from other natural sweeteners and sugar substitutes.
- 3.7 Innovation & sustainability
- 3.8 Growth potential analysis, 2023
- 3.9 Porters Analysis
- 3.9.1 Industry rivalry
- 3.9.2 Buyer power
- 3.9.3 Supplier power
- 3.9.4 Threat of new entrants
- 3.9.5 Threat of substitutes
- 3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis, 2023
- 4.3 Global company market share analysis, 2023
- 4.3.1 Company market share analysis, by region, 2023
- 4.3.1.1 North America
- 4.3.1.2 Europe
- 4.3.1.3 Asia Pacific
- 4.3.1.4 Latin America
- 4.3.1.5 Middle East & Africa
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Xylose Market Size and Forecast, By Type 2018 - 2032
- 5.1 Key type trends
- 5.2 D-Xylose
- 5.3 L-Xylose
Chapter 6 Xylose Market Size and Forecast, By Form2018 - 2032
- 6.1 Key form trend
- 6.2 Powder
- 6.3 Liquid
Chapter 7 Xylose Market Size and Forecast, By End use 2018 - 2032
- 7.1 Key end-use trends
- 7.2 Food & Beverage industry
- 7.3 Pharmaceuticals industry
- 7.4 Animal feed industry
- 7.5 Cosmetics & Personal care industry
- 7.6 Others
Chapter 8 Xylose Market Size and Forecast, By Region 2018 - 2032
- 8.1 Key trends, by region
- 8.2 North America
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Poland
- 8.3.8 Russia
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Indonesia
- 8.4.7 Thailand
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
Chapter 9 Company Profiles
- 9.1 Ardilla Technologies Limited
- 9.2 AvanceChem
- 9.3 Central Drug House P
- 9.4 Healtang Biotech Co.
- 9.5 International Flavour & Fragrance Limited
- 9.6 Penta Manufacturer
- 9.7 Sinofi Ingredients
- 9.8 Spectrum Chemicals
- 9.9 Sure Chemicals Co. Ltd.
- 9.10 Shandong Xieli Bio-tech Co., Ltd.
- 9.11 Stora Enso
- 9.12 Futaste Co., Ltd.
- 9.13 Shandong LuJian Biological Technology Co., Ltd.
- 9.14 Anyang City Yuxin Xylitol Technology Co., Ltd.
- 9.15 Jilin Yuxin Biotechnology Co., Ltd.
°ü·ÃÀÚ·á